Novel crystalline forms of antiviral benzimidazole compound

Disclosed are several crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-â-L-ribofuranosyl-1H-benzimidazole characterised by X-ray diffraction patterns described herein. The crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-â-L-ribofuranosyl-1H-benzimidazole are used in the manufacture of a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GLOVER, BOBBY NEAL, SCHMITT, ERIC ALLEN, SICKLES, BARRY RIDDLE, CARTER, BARRY HOWARD, LONG, STACEY TODD, LANCASTER, ROBERT WILLIAM, HUANG, LIAN-FENG, RIZZOLIO, MICHELE CATHERINE
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed are several crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-â-L-ribofuranosyl-1H-benzimidazole characterised by X-ray diffraction patterns described herein. The crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-â-L-ribofuranosyl-1H-benzimidazole are used in the manufacture of a medicaments for treating viral infections. Also disclosed is a process for the production of 5,6-dichloro-2-(isopropylamino)-1-â-L-ribofuranosyl-1H-benzimidazole in an anhydrous crystalline form.